Liver Failure (Hepatic Insufficiency) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Liver Failure (Hepatic Insufficiency) – Drugs In Development, 2024 report and make more profitable business decisions.
Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea, and loss of appetite. Since these symptoms are associated with a host of other conditions, it may take some time before the correct diagnosis is made. As liver failure worsens, people may experience disorientation and drowsiness. At this stage, there is a risk of coma and death.
The Liver Failure (Hepatic Insufficiency) drugs in development market research report provide comprehensive information on the therapeutics under development for Liver Failure (Hepatic Insufficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Liver Failure (Hepatic Insufficiency) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Liver Failure (Hepatic Insufficiency) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 46 molecules, with 41 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Liver Failure (Hepatic Insufficiency) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Liver Failure (Hepatic Insufficiency) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Liver Failure (Hepatic Insufficiency) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Akaza Bioscience LtdAN2 Therapeutics Inc
Arch Biopartners Inc
Bopin (Shanghai) Biomedical Technology Co Ltd
Bristol-Myers Squibb Co
Cellaion SA
Creative Medical Technology Holdings Inc
Evive Biotech
Galmed Pharmaceuticals Ltd
Genesen Co Ltd
Genfit SA
Glycan Therapeutics Inc
GNI Group Ltd
GoLiver Therapeutics
Guangzhou Saijun Biological Technology Co Ltd
HepaRegeniX GmbH
Huaxia Source Cell Engineering Group Co Ltd
iTolerance Inc
Jiangsu Hengrui Medicine Co Ltd
King's College Hospital NHS Trust R&D Consortium
Mina Therapeutics Ltd
Mitopower LLC
Orgenesis Inc
Pittsburgh ReLiver Inc
PrimeGen Global Inc
Proterris Inc
Relmada Therapeutics Inc
SeaBeLife Spas
Shanghai Hexaell Biotech Co Ltd
Shenzhen Wingor Biotechnology Co Ltd
Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd
Shiftbio Co Ltd
SK Life Science Inc
Sun Yat-sen University
The Healthy Aging Co
The Queen’s Medical Research Institute
Tianjin Angsai Cell Genetic Engineering Co Ltd
Unicyte AG
University of California San Francisco
University of Edinburgh
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Liver Failure (Hepatic Insufficiency) reports